| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Clozapine | FAERS: 11 | US FAERS | |
| 2 | Fingolimod Hydrochloride | FAERS: 4 | US FAERS | |
| 3 | rofecoxib | FAERS: 4 | US FAERS | |
| 4 | Ruxolitinib phosphate | FAERS: 2 | US FAERS | |
| 5 | Temozolomide | FAERS: 2 | US FAERS | |
| 6 | tofacitinib | FAERS: 2 | US FAERS | |
| 7 | Carbamazepine | FAERS: 1 | US FAERS | |
| 8 | Dimethyl Fumarate | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 10 | Isotretinoin | FAERS: 1 | US FAERS | |
| 11 | LCZ 696 | FAERS: 1 | US FAERS | |
| 12 | Latanoprost | FAERS: 1 | US FAERS | |
| 13 | Loxapine | FAERS: 1 | US FAERS | |
| 14 | Methotrexate | FAERS: 1 | US FAERS | |
| 15 | Tacrolimus | FAERS: 1 | US FAERS | |
| 16 | Tin Fluorides | FAERS: 1 | US FAERS | |
| 17 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 18 | eltrombopag | FAERS: 1 | US FAERS | |
| 19 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS | |
| 20 | niraparib | FAERS: 1 | US FAERS | |
| 21 | Cefaclor | OFFSIDES | ||
| 22 | Cephalexin | OFFSIDES | ||
| 23 | Dexamethasone | OFFSIDES | ||
| 24 | Lamotrigine | OFFSIDES | ||
| 25 | Megestrol Acetate | OFFSIDES | ||
| 26 | Memantine | OFFSIDES | ||
| 27 | Naltrexone | OFFSIDES | ||
| 28 | Nizatidine | OFFSIDES | ||
| 29 | Nystatin | OFFSIDES | ||
| 30 | Pamidronate | OFFSIDES | ||
| 31 | Pemetrexed | OFFSIDES | ||
| 32 | Risperidone | OFFSIDES | ||
| 33 | Sitagliptin Phosphate | OFFSIDES | ||
| 34 | Tamoxifen | OFFSIDES | ||
| 35 | Tretinoin | OFFSIDES | ||
| 36 | dofetilide | OFFSIDES | ||
| 37 | isosorbide-5-mononitrate | OFFSIDES | ||
| 38 | urapidil | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.